English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
×
Site Menu
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
PRNewsWire - Health
Insulin Delivery Device Market worth $52.7 billion by 2030 with 8.3% CAGR | MarketsandMarkets™.
Insulin Delivery Device Market worth $52.7 billion by 2030 with 8.3% CAGR | MarketsandMarkets™.
Share this via
Full Coverage
Ivy Rehab for Kids Announces Strategic Partnership with Coastline Therapy Group
Ivy Rehab for Kids Announces Strategic Partnership with Coastline Therapy Group
Share this via
Full Coverage
New ACS Cancer Atlas: Global Report Shows Nearly Half of Cancer Mortality Worldwide Attributable to Potentially Modifiable Risk Factors
New ACS Cancer Atlas: Global Report Shows Nearly Half of Cancer Mortality Worldwide Attributable to ...
Share this via
Full Coverage
Hamlet BioPharma Holds Successful In Person Meeting with US FDA
Hamlet BioPharma Holds Successful In Person Meeting with US FDA
Share this via
Full Coverage
First
Prev.
89
90
91
92
93
94
95
Next
Last
Trending
1.
Joann's closing
2.
Texas Tech basketball
3.
UNC basketball
4.
Monster Hunter Wilds
5.
Ketamine
6.
Macron
7.
UPMC Memorial shooting
8.
Eagles
9.
Hims stock
10.
Joel Embiid
Popular News
The mortgage market hopes for rate cuts amid war moves
1 week ago
15
The mortgage market hopes for rate cuts amid war moves
Share this via
BrightGene präsentiert positive Phase-2-Daten für den Dual-G...
1 week ago
13
BrightGene präsentiert positive Phase-2-Daten für den Dual-GLP-1R/GIPR-Agonisten zur Gewichtsregulat...
Share this via
Ukraine returns bodies of 3 Russian soldiers repatriated as ...
1 week ago
11
Ukraine returns bodies of 3 Russian soldiers repatriated as remains of Ukrainians, Interior Ministry...
Share this via
BrightGene presenteert positieve fase 2 gegevens voor de dua...
1 week ago
11
BrightGene presenteert positieve fase 2 gegevens voor de duale GLP-1R/GIPR agonist voor gewichtsbehe...
Share this via
BrightGene présente des données positives de phase 2 pour so...
1 week ago
10
BrightGene présente des données positives de phase 2 pour son agoniste double GLP-1R/GIPR dans la ge...
Share this via